Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Fabiana Ostronoff, Megan Othus, Robert B. Gerbing, Michael R. Loken, Susana C. Raimondi, Betsy A. Hirsch, Beverly J. Lange, Stephen Petersdorf, Jerald Radich, Frederick R. Appelbaum, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi

Blood (2014) 124 (15): 2400–2407.

https://doi.org/10.1182/blood-2014-04-570929

Published: 2014

Includes: Supplemental data

Journal Articles

NUP98/NSD1 Translocation Further Risk-Stratifies Patients With FLT3/ITD In Acute Myeloid Leukemia: A Report From Children’s Oncology Group and SWOG

Fabiana Ostronoff, MD, Megan Othus, PhD, Robert B. Gerbing, MA, Michael R. Loken, PhD, Susana C Raimondi, PhD, Betsy A. Hirsch, PhD, Beverly J. Lange, MD, Stephen Petersdorf, MD, Jerald Radich, MD, Frederick R. Appelbaum, MD, Alan S. Gamis, MD, MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 488.

https://doi.org/10.1182/blood.V122.21.488.488

Published: 2013

Journal Articles

FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report

Michele S. Redell, Marcos J. Ruiz, Robert B. Gerbing, Todd A. Alonzo, Beverly J. Lange, David J. Tweardy, Soheil Meshinchi

Blood (2013) 121 (7): 1083–1093.

https://doi.org/10.1182/blood-2012-04-421925

Published: 2013

Includes: Supplemental data

Journal Articles

Outcome of Pediatric Patients with Acute Myeloid Leukemia and -5/5q-Abnormalities Enrolled On Five Children's Oncology Group Acute Myeloid Leukemia Treatment Protocols

Donna L Johnston, MD, FRCPC, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Betsy A. Hirsch, PhD, Nyla A. Heerema, PhD, Yaddanapudi Ravindranath, MBBS, William G. Woods, MD, Beverly J. Lange, MD, Alan S. Gamis, MD, MPH, Susana C. Raimondi, PhD

Blood (2012) 120 (21): 1414.

https://doi.org/10.1182/blood.V120.21.1414.1414

Published: 2012

Journal Articles

Hematopoietic Cell Transplant Versus Chemotherapy As Consolidation Treatment for Pediatric AML with Poor-Risk Cytogenetics

Michael J. Kelly, MD, MPH, John T. Horan, M.D., M.P.H., Todd A. Alonzo, PhD, Mary Eapen, MBBS, Robert B. Gerbing, M.A., Wensheng He, PhD, Beverly J. Lange, MD, Susan K. Parsons, MD, MRP, William G. Woods, MD

Blood (2012) 120 (21): 127.

https://doi.org/10.1182/blood.V120.21.127.127

Published: 2012

Journal Articles

WT1 snp rs16754 Genotype Predicts Treatment Related Mortality (TRM) in African-American and Asian Pediatric AML Patients: A Report From the Children's Oncology Group

Phoenix A. Ho, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Lillian Sung, MD, PhD, Richard Aplenc, MD, PhD, Jessica A. Pollard, MD, Julia Kuhn, BA, Nyla A. Heerema, PhD, Beverly J. Lange, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 1385.

https://doi.org/10.1182/blood.V120.21.1385.1385

Published: 2012

Journal Articles

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

Marc Buyse, Pierre Squifflet, Beverly J. Lange, Todd A. Alonzo, Richard A. Larson, Jonathan E. Kolitz, Stephen L. George, Clara D. Bloomfield, Sylvie Castaigne, Sylvie Chevret, Didier Blaise, Dominique Maraninchi, Kathryn J. Lucchesi, Tomasz Burzykowski

Blood (2011) 117 (26): 7007–7013.

https://doi.org/10.1182/blood-2011-02-337725

Published: 2011

Includes: Supplemental data

Journal Articles

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

Blood (2010) 115 (12): 2372–2379.

https://doi.org/10.1182/blood-2009-09-241075

Published: 2010

Journal Articles

T(11q23): brand necessary

Beverly J. Lange

Blood (2009) 114 (12): 2365–2366.

https://doi.org/10.1182/blood-2009-07-229914

Published: 2009

Journal Articles

Structural and numerical variation of FLT3/ITD in pediatric AML

Soheil Meshinchi, Derek L. Stirewalt, Todd A. Alonzo, Titus J. Boggon, Robert B. Gerbing, Jennifer L. Rocnik, Beverly J. Lange, D. Gary Gilliland, Jerald P. Radich

Blood (2008) 111 (10): 4930–4933.

https://doi.org/10.1182/blood-2008-01-117770

Published: 2008

Journal Articles

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Beverly J. Lange, Franklin O. Smith, James Feusner, Dorothy R. Barnard, Patricia Dinndorf, Stephen Feig, Nyla A. Heerema, Carola Arndt, Robert J. Arceci, Nita Seibel, Margie Weiman, Kathryn Dusenbery, Kevin Shannon, Sandra Luna-Fineman, Robert B. Gerbing, Todd A. Alonzo

Blood (2008) 111 (3): 1044–1053.

https://doi.org/10.1182/blood-2007-04-084293

Published: 2008

Includes: Supplemental data

Journal Articles

A Phase I Trial of Sirolimus (Rapamycin) in Pediatric Patients with Relapsed/Refractory Leukemia.

Susan R. Rheingold, MD, Nancy Sacks, MS, RD, LDN, Yueh J. Chang, PhD, Valerie I. Brown, MD, PhD, David T. Teachey, MD, Beverly J. Lange, MD, Stephan A. Grupp, MD, PhD

Blood (2007) 110 (11): 2834.

https://doi.org/10.1182/blood.V110.11.2834.2834

Published: 2007

Journal Articles

The Presence of Central Nervous System Disease at Diagnosis in Pediatric Acute Myeloid Leukemia Does Not Affect Outcome.

Donna L. Johnston, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Beverly J. Lange, MD, William G. Woods, MD

Blood (2007) 110 (11): 1827.

https://doi.org/10.1182/blood.V110.11.1827.1827

Published: 2007

Journal Articles

Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

Lillian Sung, Beverly J. Lange, Robert B. Gerbing, Todd A. Alonzo, James Feusner

Blood (2007) 110 (10): 3532–3539.

https://doi.org/10.1182/blood-2007-05-091942

Published: 2007

Includes: Supplemental data

Journal Articles

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961

Draga Barbaric, Todd A. Alonzo, Robert B. Gerbing, Soheil Meshinchi, Nyla A. Heerema, Dorothy R. Barnard, Beverly J. Lange, William G. Woods, Robert J. Arceci, Franklin O. Smith

Blood (2006) 109 (6): 2314–2321.

https://doi.org/10.1182/blood-2005-11-025536

Published: 2006

Includes: Supplemental data

Journal Articles

Clinical implications of FLT3 mutations in pediatric AML

Soheil Meshinchi, Todd A. Alonzo, Derek L. Stirewalt, Michel Zwaan, Martin Zimmerman, Dirk Reinhardt, Gertjan J. L. Kaspers, Nyla A. Heerema, Robert Gerbing, Beverly J. Lange, Jerald P. Radich

Blood (2006) 108 (12): 3654–3661.

https://doi.org/10.1182/blood-2006-03-009233

Published: 2006

Journal Articles

Cytidine Deaminase Genotype Modifies the Toxicity of Therapy for Childhood AML.

Deepika Bhatla, MD, Robert B. Gerbing, MS, Heather D. Conner, BS, Todd A. Alonzo, PhD, Xiaowen Zhai, MD, Parinda Mehta, MD, Julie A. Ross, PhD, Hartmut Geiger, PhD, Beverly J. Lange, MD, John P. Perentesis, MD, Stella M. Davies, MBBS, PhD

Blood (2006) 108 (11): 17.

https://doi.org/10.1182/blood.V108.11.17.17

Published: 2006

Journal Articles

FLT3 internal tandem duplication in CD34 + /CD33 - precursors predicts poor outcome in acute myeloid leukemia

Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, William G. Woods, Beverly J. Lange, David A. Sweetser, Jerald P. Radich, Irwin D. Bernstein, Soheil Meshinchi

Blood (2006) 108 (8): 2764–2769.

https://doi.org/10.1182/blood-2006-04-012260

Published: 2006

Journal Articles

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group

Richard Aplenc, Todd A. Alonzo, Robert B. Gerbing, Franklin O. Smith, Soheil Meshinchi, Julie A. Ross, John Perentesis, William G. Woods, Beverly J. Lange, Stella M. Davies

Blood (2006) 108 (1): 74–80.

https://doi.org/10.1182/blood-2005-10-4004

Published: 2006

Includes: Supplemental data

Journal Articles

XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report

Parinda A. Mehta, Todd A. Alonzo, Robert B. Gerbing, James S. Elliott, Tiffany A. Wilke, Rebekah J. Kennedy, Julie A. Ross, John P. Perentesis, Beverly J. Lange, Stella M. Davies

Blood (2006) 107 (1): 39–45.

https://doi.org/10.1182/blood-2005-06-2305

Published: 2006

NARROW

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

NUP98/NSD1 Translocation Further Risk-Stratifies Patients With FLT3/ITD In Acute Myeloid Leukemia: A Report From Children’s Oncology Group and SWOG

FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report

Outcome of Pediatric Patients with Acute Myeloid Leukemia and -5/5q-Abnormalities Enrolled On Five Children's Oncology Group Acute Myeloid Leukemia Treatment Protocols

Hematopoietic Cell Transplant Versus Chemotherapy As Consolidation Treatment for Pediatric AML with Poor-Risk Cytogenetics

WT1 snp rs16754 Genotype Predicts Treatment Related Mortality (TRM) in African-American and Asian Pediatric AML Patients: A Report From the Children's Oncology Group

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

T(11q23): brand necessary

Structural and numerical variation of FLT3/ITD in pediatric AML

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

A Phase I Trial of Sirolimus (Rapamycin) in Pediatric Patients with Relapsed/Refractory Leukemia.

The Presence of Central Nervous System Disease at Diagnosis in Pediatric Acute Myeloid Leukemia Does Not Affect Outcome.

Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961

Clinical implications of FLT3 mutations in pediatric AML

Cytidine Deaminase Genotype Modifies the Toxicity of Therapy for Childhood AML.

FLT3 internal tandem duplication in CD34 + /CD33 - precursors predicts poor outcome in acute myeloid leukemia

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group

XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only